CD73 INHIBITORS

Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.

Saved in:
Bibliographic Details
Main Authors EKSTEROWICZ, John, MOORE, Jared, PHAM, Johnny, WU, Kejia, YE, Qiuping, BLANK, Brian, R, REW, Yosup, ZAVOROTINSKAYA, Tatiana, ZHU, Liusheng, SUN, Daqing, DU, Xiaohui, KAWAI, Hiroyuki, FANTIN, Valeria, R
Format Patent
LanguageEnglish
French
German
Published 02.03.2022
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Bibliography:Application Number: EP20190796584